KDR and pulmonary arterial hypertension: All biomarkers investigated have been found to be significantly altered in PAH patients of various subtypes when compared with healthy controls (Supplementary Table 1)—NO and VEGFR-2 appear lower in patient blood when compared to healthy controls, while all other markers are elevated.